BioCardia, Inc. (BCDA) vs Cellectar Biosciences, Inc. (CLRB)
A side-by-side comparison of BioCardia, Inc. and Cellectar Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCDA
BioCardia, Inc.
$1.10HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
CLRB
Cellectar Biosciences, Inc.
$1.66HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
Total return — BCDA vs CLRB
growth of $100 · dividends reinvested · last 10yBCDA -99.8% (-46.5%/yr)CLRB -100.0% (-55.5%/yr)BCDA compounded faster over this window
Log scale — wide-divergence pair
BCDA CLRB
BCDA vs CLRB: by the numbers
- •BCDA is the larger company ($16M vs $13M market cap).
Metrics side by side
Valuation
| Metric | BCDA | CLRB |
|---|---|---|
| P/B ratio | 6.09 | 0.44 |
Profitability
| Metric | BCDA | CLRB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -271.81% | -74.73% |
| ROIC | -273.70% | -74.94% |
Growth (annualized)
| Metric | BCDA | CLRB |
|---|---|---|
| Total return CAGR (5Y) | -61.39% | -60.51% |
Frequently asked
- How have BCDA and CLRB total returns compared?
- Over the past 10 years, BCDA delivered -46.74% and CLRB delivered -55.35% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.